Erytech’s Success with CapDecisif Management

Welcome to our channel! In this video, you will learn about Heritage Pharma, a pioneering company focused on improving drug efficacy and reducing toxicity through the encapsulation of drugs inside red blood cells. Our co-founder and Chief Scientific Officer, Ian Go Train, will guide you through our journey.

Established in 2004, Heritage Pharma has been at the forefront of encapsulating drugs in erythrocytes, with the aim of revolutionizing drug delivery. Our lead product, Asparagines, has shown promising results in treating leukemias during extensive clinical trials. Recently, we have submitted a market authorization application to the European Agency, CAP Decisive.

Our early partnership with CAP was crucial to our progress, with their investment in our company just a year after incorporation. As a testament to our growth, we have been listed on the European market, EuroNext, since two years ago.

While we continue to expand in Europe, our focus is shifting towards the highly lucrative US market. With a subsidiary in the US, our products’ development has gained momentum. Join us as we embark on this exciting new chapter!

To stay updated on Heritage Pharma’s latest innovations and breakthroughs, make sure to subscribe to our channel and hit the notification bell. Feel free to leave any questions or comments below. Thank you for watching!

– [Heritage Pharma Official Website](
– [European Agency for the Evaluation of Medicinal Products (EMA)](
– [EuroNext Stock Exchange](

14 dec 2015

Leave a Reply

Your email address will not be published. Required fields are marked *

GIPHY App Key not set. Please check settings

Recap 3 of the Biennale Teatro 2023: Masterclass, El Conde de Torrefiel, Andersson

The Vital Role of the Board in CEO Succession Planning: Unveiling the Truth